3 PM - 4 PM
IRB Education Session
DHMC, Borwell 758W
11 AM - 1 PM
GSMD Registrar's Suite, DHMC
Fees for activities involved in the submission and review by the Committee for the Protection of Human Subjects (CPHS) will be charged to each industry sponsored clinical trial. In collaboration with the Dartmouth Clinical Trials Office the established fees are outlined below:
Full Committee Initial Review:
o $3500 ($2000 for CPHS activities and $1500 for departmental activities)
Expedited Review Initial Review (non-federally funded research):
o $1500 ($750 for Committee activities and $750 for departmental activities)
Full Committee Modifications:
o $1500: ($500 for CPHS activities and $1000 for departmental activities)
Full Committee Continuing Reviews:
o $1500 ($500 for CPHS activities and $1000 for departmental activities)
Deferment to a Commercial IRB:
o $2000 ($500 for CPHS activities and $1500 for departmental activities)
Detailed justification for the fees will be supplied to industry sponsors in a welcome letter sent at the beginning of all budget negotiations. In addition, the CTO will include these fees as part of all the budgets they prepare and negotiate with industry sponsors.
The CPHS Office will send invoices to the Clinical Trials Office (CTO) for the CPHS portion of the fee. The CTO will manage invoicing the sponsor and distributing the funds appropriately.
Special requests for a waiver of the fee should be emailed to firstname.lastname@example.org
A June 2011 memo describes the CPHS review fees that became effective on July 1, 2011.
An October 2013 memo describes the fee changes that became effective on November 1, 2013.
If you encounter difficulties in making payments for CPHS fees, please consult the CPHS office by email at email@example.com or by telephone at (603) 646-6482.
Last Updated: 10/8/15